The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer
Official Title: A Randomized, Controlled, Multi-Center Clinical Trial to Evaluate the Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer
Study ID: NCT04992026
Brief Summary: This randomized, controlled, multi-center clinical trial aims to evaluate the efficacy and safety of prostatectomy for castration-Naive oligometastatic prostate cancer
Detailed Description:
Minimum Age: 40 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China
Name: Hongqian Guo, MD
Affiliation: Nanjing Drum Tower Hospital, affiliated to medical school of Nanjing University
Role: PRINCIPAL_INVESTIGATOR